Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Hip-focused Neuromuscular Activation Exercise on Foot Posture and Neuromuscular Control

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03916991
Recruitment Status : Not yet recruiting
First Posted : April 16, 2019
Last Update Posted : April 16, 2019
Sponsor:
Information provided by (Responsible Party):
Elif Turgut, Hacettepe University

Brief Summary:
This study planned to investigate the effect of hip-focused neuromuscular activation exercise on foot posture and neuromuscular control in symptomatic and asymptomatic participants. We will follow a cross-over study design to compare the effect of hip focused neuromuscular activation exercise or a sham exercise on foot posture and lower extremity biomechanics. Foot posture will be assessed by Navicular Drop Test (NDT), and lower extremity neuromuscular control will be assessed with Star Excursion Y-Balance Test (SEBT-Y) and Frontal Plane Projection Angle (FPPA) during single leg squat before and after the experiments. The results of this study may provide scientific knowledge for a kinetic chain approach during functional foot rehabilitation.

Condition or disease Intervention/treatment Phase
Exercise Other: Exercise Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: A cross-over study to investigate the effect of hip-focused neuromuscular activation exercise on foot posture and neuromuscular control
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Cross-over Study to Investigate the Effect of Hip-focused Neuromuscular Activation Exercise on Foot Posture and Neuromuscular Control
Estimated Study Start Date : April 12, 2019
Estimated Primary Completion Date : June 12, 2019
Estimated Study Completion Date : July 12, 2019


Arm Intervention/treatment
Experimental: Neuromuscular Exercise
Neuromuscular Exercise
Other: Exercise
Hip focused Neuromuscular Activation Exercise

No Intervention: Control
No intervention
Sham Comparator: Sham Exercise
Sham Exercise
Other: Exercise
Hip focused Neuromuscular Activation Exercise




Primary Outcome Measures :
  1. Navicular Drop Test [ Time Frame: 1 year ]
    Navicular Drop Test


Secondary Outcome Measures :
  1. Star Excursion Y-Balance Test [ Time Frame: 1 year ]
    Star Excursion Y-Balance Test

  2. Frontal Plane Projection Angle [ Time Frame: 1 year ]
    Frontal Plane Projection Angle



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • To be included, participants should be between the ages of 18 and 45 years.

Exclusion Criteria:

  • Participants will be excluded from this study if they have a history of lower body trauma or surgery, or positive trendelenburg sign and slump test.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03916991


Contacts
Layout table for location contacts
Contact: Elif Turgut, PhD 00903123051576 elifcamci@hacettepe.edu.tr

Sponsors and Collaborators
Hacettepe University
Investigators
Layout table for investigator information
Principal Investigator: Elif Turgut, PhD Hacettepe University
Layout table for additonal information
Responsible Party: Elif Turgut, Associate Proffessor, Hacettepe University
ClinicalTrials.gov Identifier: NCT03916991    
Other Study ID Numbers: GO16542
First Posted: April 16, 2019    Key Record Dates
Last Update Posted: April 16, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No